Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 


Breakthrough Influenza Treatment To Be Available

Breakthrough Influenza Treatment To Be Available This Winter

MEDIACOM-RELEASE-GLAXO-WELLCOME-NZ-LTD

BREAKTHROUGH INFLUENZA TREATMENT TO BE AVAILABLE THIS WINTER

New Zealand influenza sufferers now have access to a breakthrough product for the treatment of influenza, Relenza (Zanamavir). Glaxo Wellcome NZ managing director Steve Skolsky says approval and registration processes have just been completed for the product, which will be available as a prescription medicine from 1 July.

Mr Skolsky says interest in the new product has been high because of the current influenza epidemic. "There has been considerable anticipation for Relenza because it finally offers a treatment for the causes of influenza where, in the past, there have been no effective options."

Key points

----------

1. Relenza is administered using an oral inhaler and is a prescription-only medicine. Influenza is a viral infection of the lungs, and administering Relenza by inhalationensures it gets straight to the site of infection, with minimal side effects.

2. Relenza should be used within 48 hours of developing influenza.

3. Clinical trials in Australia, New Zealand and South Africa showed that patients with influenza treated with Relenza experienced a significant reduction in the severity of their symptoms (see references in attached detailed release).Note: Patients suffering from influenza-like symptoms should consult with their general practitioner at the onset of symptoms.

4. The cost to patients of a five-day treatment will be approximately $60-70. Relenza has not received government funding.

5. Relenza was invented in Australia in the 1990s by Glaxo Wellcome and Australian company, Biota Holdings.

(Continues - see next release)

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Onetai Station: Overseas Investment Office Puts Ceol & Muir On Notice

The Overseas Investment Office (OIO) has issued a formal warning to Ceol & Muir and its owners, Argentinian brothers Rafael and Federico Grozovsky, for failing to provide complete and accurate information when they applied to buy Onetai Station in 2013. More>>

ALSO:

Tomorrow, The UN: Feds President Takes Reins At World Farming Body

Federated Farmers president Dr William Rolleston has been appointed acting president of the World Farmers’ Organisation (WFO) at a meeting in Geneva overnight. More>>

ALSO:

I Sing The Highway Electric: Charge Net NZ To Connect New Zealand

BMW is turning Middle Earth electric after today announcing a substantial contribution to the charging network Charge Net NZ. This landmark partnership will enable Kiwis to drive their electric vehicles (EVs) right across New Zealand through the installation of a fast charging highway stretching from Kaitaia to Invercargill. More>>

ALSO:

Watch This Space: Mahia Rocket Lab Launch Site Officially Opened

Economic Development Minster Steven Joyce today opened New Zealand’s first orbital launch site, Rocket Lab Launch Complex 1, on the Mahia Peninsula on the North Island’s east coast. More>>

Earlier:

Marketing Rocks!
Ig Nobel Award Winners Assess The Personality Of Rocks

A Massey University marketing lecturer has received the 2016 Ig Nobel Prize for economics for a research project that asked university students to describe the “brand personalities” of three rocks. More>>

ALSO:

Nurofen Promotion: Reckitt Benckiser To Plead Guilty To Misleading Ads

Reckitt Benckiser (New Zealand) intends to plead guilty to charges of misleading consumers over the way it promoted a range of Nurofen products, the Commerce Commission says. More>>

ALSO:

Get More From Scoop

 
 
 
 
 
 
 
 
 
Sci-Tech
Search Scoop  
 
 
Powered by Vodafone
NZ independent news